AUD 0.07
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -4.91 Million AUD | -6.01% |
2022 | -5.43 Million USD | -179.47% |
2021 | -2.52 Million AUD | 77.64% |
2020 | -8.84 Million AUD | 28.51% |
2019 | -12.37 Million AUD | 26.83% |
2018 | -16.91 Million AUD | -8.56% |
2017 | -16.27 Million AUD | -188.05% |
2016 | -6.18 Million AUD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 Q2 | -1.43 Million USD | -0.37% |
2023 Q3 | -1.59 Million USD | -10.81% |
2023 FY | - AUD | -6.01% |
2023 Q4 | -1.5 Million USD | 5.68% |
2023 Q1 | -1.43 Million USD | 24.88% |
2022 Q3 | -2.02 Million USD | 11.79% |
2022 Q4 | -1.9 Million USD | 6.05% |
2022 FY | - USD | -179.47% |
2022 Q2 | -2.3 Million USD | 0.0% |
2021 FY | - AUD | 77.64% |
2020 FY | - AUD | 28.51% |
2019 Q2 | -4.44 Million AUD | 0.0% |
2019 Q1 | -4.44 Million AUD | 0.0% |
2019 FY | - AUD | 26.83% |
2018 Q1 | -5.92 Million AUD | 0.0% |
2018 FY | - AUD | -8.56% |
2018 Q4 | -4.44 Million AUD | 0.0% |
2018 Q2 | -5.92 Million AUD | 0.0% |
2017 Q1 | -5 Million AUD | 0.0% |
2017 Q2 | -5 Million AUD | 0.0% |
2017 Q4 | - AUD | 0.0% |
2017 FY | - AUD | -188.05% |
2016 Q2 | - AUD | 0.0% |
2016 Q1 | - AUD | 0.0% |
2016 Q4 | -5 Million AUD | 0.0% |
2016 FY | - AUD | 0.0% |
2015 Q4 | - AUD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
4DMedical Limited | -36.06 Million AUD | 86.366% |
Adherium Limited | -11.56 Million AUD | 57.478% |
Aroa Biosurgery Limited | -7.36 Million AUD | 33.188% |
Atomo Diagnostics Limited | -5.42 Million AUD | 9.332% |
Anteris Technologies Ltd | -66.9 Million AUD | 92.65% |
Control Bionics Limited | -5.15 Million AUD | 4.669% |
CardieX Limited | -6.71 Million AUD | 26.736% |
Compumedics Limited | 2.78 Million AUD | 276.314% |
Cochlear Limited | 579.5 Million AUD | 100.849% |
CleanSpace Holdings Limited | -3.49 Million AUD | -40.827% |
Cyclopharm Limited | -3.03 Million AUD | -62.028% |
EMVision Medical Devices Ltd | -2.09 Million AUD | -135.146% |
Nova Eye Medical Limited | -5.97 Million AUD | 17.756% |
HeraMED Limited | -3.97 Million AUD | -23.8% |
Imricor Medical Systems, Inc. | -21.87 Million AUD | 77.516% |
ImpediMed Limited | -22.05 Million AUD | 77.7% |
InhaleRx Limited | -1.41 Million AUD | -247.828% |
LBT Innovations Limited | -4.04 Million AUD | -21.447% |
Micro-X Limited | -14.35 Million AUD | 65.735% |
Neurotech International Limited | -8.24 Million AUD | 40.352% |
OncoSil Medical Limited | -11.97 Million AUD | 58.94% |
PolyNovo Limited | 5.17 Million AUD | 195.114% |
Respiri Limited | -7.04 Million AUD | 30.249% |
SomnoMed Limited | -2.32 Million AUD | -111.173% |
Universal Biosensors, Inc. | -9.09 Million AUD | 45.906% |
Uscom Limited | -1.5 Million AUD | -225.804% |